Research-Action in Hematology From Hospitalization to Home

NCT06053918 | Completed

• 1 other identifier: 18-199
• Study Type: observational
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

Objective : To study and support the hospitalization and the return home of patients with the help of a psychological follow-up started in a hospital institution and which will continue in the patient's home, based on the concepts of transitionality and narrativity. Material and method To do this, the subjects will benefit from psychological interviews where they will freely discuss what concerns them, whether it is illness, treatment, returning home, or any other personal subject. They will be divided into two groups of 5 patients each, one of the groups will benefit from follow-up in an institution as contracted for several years between the Institute of Hematology and the psychologists of the UMDSP, another from the same follow-up but with the presence of the psychologist at the time of discharge extended to the patient's home after leaving the hospital for a period of 2 months. To ensure a certain consistency in the evaluation criteria, these will be standardized in the form of questionnaires completed blindly by the patient, a caregiver and the investigator, at 3 key times of the research (entry, discharge from hospital, two months after this discharge) Device tested: The aim of this work is to test the benefits of a device based on transitionality, which can limit, thanks to the restoration of the symbolization process, the deleterious effects of each of the stages imposed by the disease, the care and the resumption of autonomy once the active phase of care has passed. Narrativity is also at the heart of this transitional device. It makes it possible to evoke the present experience of the patient in connection with future projects and in the continuity of past, potentially traumatic events. It opens onto a dynamic temporal perspective where the trauma freezes. The whole process promotes the subjective reappropriation of the experience and a psychic well-being.

Conditions

Hematologic Cancer

Outcome Measures

Primary Outcomes (1)

• Clinical evaluation of the psychological state, anxiety-depressive disorders

  anxiety-depressive disorders yes or no

  At hospital Month 0 and at home Month 2

Study Arms (2)

classic follow-up (Group A)

Group A will benefit from the classic follow-up, as it has been contractualized for several years now between the UMDSP and the hematology sector. Namely a psychological follow-up in the patient's room during the hospitalization time, once a week, more if the patient is going through a difficult passage that requires closer support. This follow-up is spread over an approximate period of 6 weeks maximum, depending on the length of hospitalization

Intervention group (Group B)

Group B will benefit from this same follow-up, to which will be added an interview when leaving the sector, and the extension of follow-up of the patient at home according to the same conditions: once a week, more if necessary, over a period of two months. This follow-up is spread over an approximate period of 15 weeks maximum, depending on the length of hospitalization.

Other: additional follow-up extension at home

Interventions

additional follow-up extension at home OTHER

additional interview when leaving the sector, and the extension of follow-up of the patient at home

Intervention group (Group B)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Hospitalized patient in Protected Hematology Unit

You may qualify if:

• patient hospitalized Protected Hematology Unit
• patient with haematologic cancer
• patient requesting psychological assistance or accepting proposed psychological assistance
• signed informed consent

You may not qualify if:

• patient refusing to participate
• patient not able to participate

Sponsors & Collaborators

• University Hospital, Caen: lead

Study Sites (1)

CAEN University Hospital

Caen, France

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 28, 2023
• First Posted: September 26, 2023
• Study Start: May 7, 2019
• Primary Completion: March 31, 2020
• Study Completion: March 31, 2021
• Last Updated: September 26, 2023

Record last verified: 2023-07

Locations

FR (1)